ShenRongGuBenHuanShao Pill ameliorates oligoasthenospermia by alleviating oxidative stress and DNA damage via activation of the PI3K/Akt/mTOR pathway.
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: ShenRongGuBenHuanShao Pill (SRGBHSP) is a classic kidney-tonifying traditional Chinese medicine formula with a clinical history of nearly a century for treating oligoasthenospermia (OA). However, systematic investigations into its therapeutic effects and underlying mechanisms remain lacking.
AIMS OF STUDY: This study aims to investigate the therapeutic effects of SRGBHSP on OA and to elucidate its underlying mechanisms.
METHODS
Network pharmacology was employed to predict the potential targets of SRGBHSP for treating OA. Subsequently, H2O2-induced GC-1 cells injury model and cyclophosphamide-induced OA rats' model were established. The therapeutic mechanism of SRGBHSP was then validated using a specific inhibitor. Finally, a multi-omics analysis was conducted to provide a systems-level understanding of the underlying mechanism.
RESULTS
Network pharmacology analysis identified 1276 potential targets of SRGBHSP for OA. Mechanistically, SRGBHSP alleviated oxidative stress, mitochondrial dysfunction, and DNA damage in GC-1 cells by activating the PI3K/Akt/mTOR pathway. In OA rats, SRGBHSP administration significantly improved semen quality, restored testicular/epididymal histology, and normalized hepatorenal function and hormone levels. The reversal of these benefits by the PI3K inhibitor LY294002 confirmed the functional necessity of this pathway. Integrative multi-omics analyses unveiled a novel systemic dimension to its action. SRGBHSP restructured gut microbiota function (enhancing carbohydrate/amino acid metabolism) and reprogrammed host metabolism, particularly the arachidonic acid pathway. Correlation networks linked these gut and metabolic changes to the activation of testicular signaling, supporting the operation of a "gut-testis" axis. This axis involved modulation of the AMPK/mTOR/PPAR transcriptional program and the cAMP/PKA/PI3K/cGMP/PKG protein network. In conclusion, SRGBHSP ameliorates OA not only by direct activation of the PI3K/Akt/mTOR pathway but also through a multi-organ mechanism involving the gut-testis axis, providing a comprehensive mechanistic framework for its therapeutic efficacy.
CONCLUSIONS
This study concludes that the therapeutic effect of SRGBHSP on OA is mediated through the activation of the PI3K/Akt/mTOR signaling pathway. Beyond this core pathway, SRGBHSP orchestrates a systemic response that involves maintaining gut-testis axis homeostasis and modulating gene expression at both the transcriptional and translational levels.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.